Jetema Co

Jetema Co AAQS

The The AAQS of Jetema Co (216080.KQ) as of Oct 15, 2026 is 2. In the previous year, The AAQS was 2.00 — a change of 0.00% (lower).

AAQS

2

YoY

0.00%

Last updated:

Jetema Co has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Jetema Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Jetema Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
2.00 KRW
Jan 1, 2019
2.00 KRW
Jan 1, 2020
2.00 KRW
Jan 1, 2021
2.00 KRW
Jan 1, 2022
2.00 KRW
Jan 1, 2023
2.00 KRW
Jan 1, 2024
2.00 KRW
Jan 1, 2025
2.00 KRW
The Jetema Co AAQS history
YEARAAQSYoY
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
2—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jetema Co Stock analysis

What does Jetema Co do? Jetema Co Ltd is a South Korean company based in Wonju, Gangwon-Do, operating within the Health Care sector, specifically in the Pharmaceuticals industry. The company focuses on the manufacturing and distribution of aesthetic medical products, including dermal fillers, threads, botulinum toxin, and other medical devices. Jetema Co Ltd went public on November 14, 2019, with its stock listed under the ticker 216080.KQ and ISIN KR7216080002. The company currently employs 187 full-time staff members. Jetema's product portfolio includes hyaluronic acid fillers designed for facial beauty treatments, as well as medical devices aimed at improving wrinkles, facial contours, and volume. Additionally, the company produces laser equipment for treating conditions such as leukoplakia, psoriasis, and alopecia areata, along with lifting medical devices, cosmetic mask packs, and pharmaceutical excipients. The company's website is www.jetema.com. Jetema Co Ltd is engaged in the development, manufacturing, and distribution of its products, with a focus on aesthetic and medical applications. The company does not disclose further details on its financial performance, acquisitions, or specific product names beyond what is publicly available. It operates primarily in South Korea, serving both domestic and international markets through its product offerings. Jetema Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jetema Co stock

The AAQS of Jetema Co is 2 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Jetema Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Jetema Co

All Key Metrics — Jetema Co